Department of Nursing and Midwifery, University of the West of England, Bristol, UK.
Academic Rheumatology Unit, University Hospitals Bristol NHS Foundation Trust, Bristol, UK.
Diabet Med. 2018 Jan;35(1):78-88. doi: 10.1111/dme.13537. Epub 2017 Nov 20.
To determine clinical outcomes and explore prognostic factors related to ulcer healing in people with a clinically infected diabetic foot ulcer.
This multicentre, prospective, observational study reviewed participants' data at 12 months after culture of a diabetic foot ulcer requiring antibiotic therapy. From participants' notes, we obtained information on the incidence of wound healing, ulcer recurrence, lower extremity amputation, lower extremity revascularization and death. We estimated the cumulative incidence of healing at 6 and 12 months, adjusted for lower extremity amputation and death using a competing risk analysis, and explored the relationship between baseline factors and healing incidence.
In the first year after culture of the index ulcer, 45/299 participants (15.1%) had died. The ulcer had healed in 136 participants (45.5%), but recurred in 13 (9.6%). An ipsilateral lower extremity amputation was recorded in 52 (17.4%) and revascularization surgery in 18 participants (6.0%). Participants with an ulcer present for ~2 months or more had a lower incidence of healing (hazard ratio 0.55, 95% CI 0.39 to 0.77), as did those with a PEDIS (perfusion, extent, depth, infection, sensation) perfusion grade of ≥2 (hazard ratio 0.37, 95% CI 0.25 to 0.55). Participants with a single ulcer on their index foot had a higher incidence of healing than those with multiple ulcers (hazard ratio 1.90, 95% CI 1.18 to 3.06).
Clinical outcomes at 12 months for people with an infected diabetic foot ulcer are generally poor. Our data confirm the adverse prognostic effect of limb ischaemia, longer ulcer duration and the presence of multiple ulcers.
确定临床结局,并探讨与临床感染性糖尿病足溃疡愈合相关的预后因素。
这是一项多中心、前瞻性、观察性研究,对需要抗生素治疗的糖尿病足溃疡培养后 12 个月的参与者数据进行了回顾。我们从参与者的记录中获得了关于伤口愈合、溃疡复发、下肢截肢、下肢血运重建和死亡的发生率信息。我们使用竞争风险分析调整了下肢截肢和死亡因素后,估计了 6 个月和 12 个月的愈合累积发生率,并探讨了基线因素与愈合发生率之间的关系。
在索引溃疡培养后的第一年,有 45/299 名参与者(15.1%)死亡。136 名参与者(45.5%)的溃疡愈合,但有 13 名(9.6%)复发。52 名(17.4%)参与者记录到同侧下肢截肢,18 名(6.0%)接受了血运重建手术。溃疡存在时间约 2 个月或更长时间的参与者愈合发生率较低(风险比 0.55,95%置信区间 0.39 至 0.77),PEDIS(灌注、范围、深度、感染、感觉)灌注等级≥2 的参与者也是如此(风险比 0.37,95%置信区间 0.25 至 0.55)。与有多个溃疡的参与者相比,索引脚上有单个溃疡的参与者愈合发生率更高(风险比 1.90,95%置信区间 1.18 至 3.06)。
感染性糖尿病足溃疡患者 12 个月的临床结局普遍较差。我们的数据证实了肢体缺血、溃疡持续时间更长和存在多个溃疡的不良预后影响。